Antigoni Lekka

699 total citations
16 papers, 556 citations indexed

About

Antigoni Lekka is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Antigoni Lekka has authored 16 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Antigoni Lekka's work include Adipokines, Inflammation, and Metabolic Diseases (7 papers), Acute Myeloid Leukemia Research (3 papers) and Biomarkers in Disease Mechanisms (3 papers). Antigoni Lekka is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (7 papers), Acute Myeloid Leukemia Research (3 papers) and Biomarkers in Disease Mechanisms (3 papers). Antigoni Lekka collaborates with scholars based in Greece, United States and Israel. Antigoni Lekka's co-authors include Μaria Dalamaga, Κωνσταντίνος Καρμανιώλας, Evangelia Papadavid, George Sotiropoulos, Christos S. Mantzoros, Amalia Dionyssiou‐Asteriou, John P. Chamberland, A. Panagiotou, Alex Hsi and Stavros Archondakis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Metabolism and Lung Cancer.

In The Last Decade

Antigoni Lekka

15 papers receiving 541 citations

Peers

Countries citing papers authored by Antigoni Lekka

Since Specialization

Citations

This map shows the geographic impact of Antigoni Lekka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antigoni Lekka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antigoni Lekka more than expected).

Fields of papers citing papers by Antigoni Lekka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antigoni Lekka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antigoni Lekka. The network helps show where Antigoni Lekka may publish in the future.

Co-authorship network of co-authors of Antigoni Lekka

This figure shows the co-authorship network connecting the top 25 collaborators of Antigoni Lekka. A scholar is included among the top collaborators of Antigoni Lekka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antigoni Lekka. Antigoni Lekka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study 2021 ·Biomolecules ·Gerasimos Socrates Christodoulatos, Georgios Antonakos, Ιrene Karampela, (unknown), Theodora Stratigou, Natalia G. Vallianou, Antigoni Lekka, Ιωάννα Μαρίνου, (unknown), Styliani Kokoris, Athanasios G. Papavassiliou, Μaria Dalamaga	25
2	Circulating plasminogen activator inhibitor-1 activity: a biomarker for resectable non-small cell lung cancer? 2020 ·PubMed ·George Sotiropoulos, (unknown), Ιrene Karampela, Gerasimos Socrates Christodoulatos, Georgios Antonakos, Ιωάννα Μαρίνου, (unknown), Antigoni Lekka, Athanasios G. Papavassiliou, Μaria Dalamaga	16
3	Classic and Novel Adipokines as diagnostic biomarkers in NSCLC 2019 ·Lung Cancer ·Georgios C. Sotiropoulos, Gerasimos Socrates Christodoulatos, Ιrene Karampela, Georgios Antonakos, Ιωάννα Μαρίνου, (unknown), (unknown), Antigoni Lekka, Athanasios G. Papavassiliou, Μaria Dalamaga	0
4	Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer 2018 ·Lung Cancer ·George Sotiropoulos, Μaria Dalamaga, Georgios Antonakos, Ιωάννα Μαρίνου, (unknown), (unknown), Ιrene Karampela, Gerasimos Socrates Christodoulatos, Antigoni Lekka, Athanasios G. Papavassiliou	30
5	Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control study 2015 ·Leukemia & lymphoma ·Μaria Dalamaga, Stergios A. Pοlyzos, Κωνσταντίνος Καρμανιώλας, John P. Chamberland, Antigoni Lekka, (unknown), Ilias Migdalis, Evangelia Papadavid, Christos S. Mantzoros	7
6	Circulating fetuin-A in patients with pancreatic cancer: a hospital-based case-control study 2014 ·Biomarkers ·Μaria Dalamaga, Stergios A. Pοlyzos, Κωνσταντίνος Καρμανιώλας, John P. Chamberland, Antigoni Lekka, Ilias Migdalis, Evangelia Papadavid, Amalia Dionyssiou‐Asteriou, Christos S. Mantzoros	11
7	Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome 2013 ·Metabolism ·Μaria Dalamaga, Κωνσταντίνος Καρμανιώλας, John P. Chamberland, (unknown), Antigoni Lekka, Amalia Dionyssiou‐Asteriou, Christos S. Mantzoros	38
8	Serum resistin: A biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters 2013 ·Clinical Biochemistry ·Μaria Dalamaga, George Sotiropoulos, Κωνσταντίνος Καρμανιώλας, (unknown), Evangelia Papadavid, Antigoni Lekka	83
9	Hyperresistinemia is associated with postmenopausal breast cancer 2013 ·Menopause The Journal of The North American Menopause Society ·Μaria Dalamaga, Κωνσταντίνος Καρμανιώλας, Evangelia Papadavid, (unknown), George Sotiropoulos, Antigoni Lekka	51
10	Could serum visfatin be a potential biomarker for postmenopausal breast cancer? 2012 ·Maturitas ·Μaria Dalamaga, Stavros Archondakis, George Sotiropoulos, Κωνσταντίνος Καρμανιώλας, (unknown), Evangelia Papadavid, Antigoni Lekka	52
11	Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters 2011 ·Menopause The Journal of The North American Menopause Society ·Μaria Dalamaga, Κωνσταντίνος Καρμανιώλας, Evangelia Papadavid, (unknown), George Sotiropoulos, Antigoni Lekka	71
12	Platelet Markers Correlate with Glycemic Indices in Diabetic, but Not Diabetic-Myelodysplastic Patients with Normal Platelet Count 2010 ·Disease Markers ·Μaria Dalamaga, Κωνσταντίνος Καρμανιώλας, Antigoni Lekka, (unknown), (unknown), Evangelia Papadavid, (unknown), Amalia Dionyssiou‐Asteriou	20
13	B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case–control study in Greece 2010 ·Cancer Causes & Control ·Μaria Dalamaga, Bradley H. Crotty, Jessica Fargnoli, Evangelia Papadavid, Antigoni Lekka, (unknown), Κωνσταντίνος Καρμανιώλας, Ilias Migdalis, Amalia Dionyssiou‐Asteriou, Christos S. Mantzoros	28
14	Platelet markers correlate with glycemic indices in diabetic, but not diabetic-myelodysplastic patients with normal platelet count. 2010 ·SHILAP Revista de lepidopterología ·Μaria Dalamaga, Κωνσταντίνος Καρμανιώλας, Antigoni Lekka, (unknown), (unknown), Evangelia Papadavid, (unknown), Amalia Dionyssiou‐Asteriou	27
15	Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case–control study 2008 ·Cancer Causes & Control ·Μaria Dalamaga, Κωνσταντίνος Καρμανιώλας, A. Panagiotou, Alex Hsi, John P. Chamberland, (unknown), Antigoni Lekka, Christos S. Mantzoros	83
16	Is thyroid autoimmunity a risk factor for developing primary myelodysplastic syndrome? 2007 ·Cancer Causes & Control ·Μaria Dalamaga, Antigoni Lekka, Κωνσταντίνος Καρμανιώλας, Eleni Stathopoulou, Amalia Dionyssiou‐Asteriou	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact